| Net Cash Provided by (Used in) Operating Activities |
$1,004,734 |
USD |
-498% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,339,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$150,000 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,458 |
USD |
946% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$899,736 |
USD |
67% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$899,736 |
USD |
67% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Interest Expense |
$162,092 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |